Brian Markison

Brian A. Markison is currently Chief Executive Officer at Osmotica Pharmaceutical Corp.
He serves as Director at The College of New Jersey, College of New Jersey Foundation, National Spine Center, The Pennington School, Komen Central & South Jersey, ACP Nimble Holdings, Inc., and National Spine Center.
He is also Industry Executive at Avista Capital Holdings LP since 2012.
Formerly, Mr. Markison was Chairman, President & Chief Executive Officer at KP Pharmaceuticals LLC from 2007 to 2011.
He was President, Chief Executive Officer & Director at Fougera Pharmaceuticals, Inc. from 2011 to 2012.
He held roles as Chairman & Chief Executive Officer at Osmotica Holdings Corp.
Ltd., RVL Pharmaceuticals Plc, and King Pharmaceuticals, Inc. He was Chief Executive Officer at Cerveau Technologies, Inc. and RVL Pharmaceuticals, Inc. He was Chief Executive Officer & Director at Lantheus Holdings, Inc. from 2024 to 2025.
He served as Chairman at Rosetta Genomics Ltd. from 2011 to 2018.
He was Executive Chairman at Vertical Pharmaceuticals LLC and Vertical.
He was Director at Immunomedics, Inc. from 2004 to 2011, Alere, Inc. in 2013, Theraclone Sciences, Inc., PharmAthene, Inc. from 2012 to 2015, Braeburn, Inc., Avista Healthcare Public Acquisition Corp., Cosette Pharmaceuticals, Inc., and Lantheus Medical Imaging, Inc. from 2012 to 2013.
He was Senior VP-Operational Excellence & Productivity at Bristol Myers Squibb Co. from 1982 to 2004.
He was President at Oncology Therapeutics Network Corp.
Mr. Markison completed undergraduate studies at Iona College in 1982.